Mucoepidermoid carcinoma surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Mucoepidermoid carcinoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology [[Category:Oral pat...")
 
No edit summary
 
(13 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
{{Mucoepidermoid carcinoma}}
{{Mucoepidermoid carcinoma}}
{{CMG}}
{{CMG}}{{AE}}{{Badria}} , {{MV}}


==Overview==
==Overview==
Surgery is the mainstay of therapy for mucoepidermoid carcinoma.
==Surgery==
*Mucoepidermoid carcinoma (low-grade): complete surgical excision with sparing of the facial nerve.<ref name="ppp">Mucoepidermoid Carcinoma Surgery. WikiBooks. https://en.wikibooks.org/wiki/Radiation_Oncology/Head_%26_Neck/Salivary_gland Accessed on February 17,2016</ref><ref name="ppp">Mucoepidermoid Carcinoma Surgery. WikiBooks. https://en.wikibooks.org/wiki/Radiation_Oncology/Head_%26_Neck/Salivary_gland Accessed on February 17,2016</ref>
*Mucoepidermoid carcinoma (high-grade): [[parotidectomy]] with [[facial nerve]] sparing may be followed by [[radiotherapy]].
*Clinically aggressive mucoepidermoid carcinoma tumors with [[facial nerve]] involvement will require radical surgery with sacrifice of the [[facial nerve]] and [[radiotherapy]]. <ref name="pmid29318070">{{cite journal |vauthors=Gedar Totuk OM, Demir MK, Yapicier O, Mestanoglu M |title=Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient |journal=Case Rep Ophthalmol Med |volume=2017 |issue= |pages=2418505 |date=2017 |pmid=29318070 |pmc=5727657 |doi=10.1155/2017/2418505 |url=}}</ref>
*Primary nerve grafting using the [[sural nerve]] if possible is performed.
*[[Lymph node]] dissection is usually only performed for detected nodal metastasis.
* Low grade mucoepidermoid carcinoma in the floor of the mouth can be surgically excised along with involved [[lymph node]].<ref name="pmid14662408">{{cite journal |vauthors=Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A |title=Management of malignant sublingual salivary gland tumors |journal=Oral Oncol. |volume=40 |issue=1 |pages=2–5 |date=January 2004 |pmid=14662408 |doi= |url=}}</ref><ref name="pmid9261001">{{cite journal |vauthors=Helmus C |title=Subtotal parotidectomy: a 10-year review (1985 to 1994) |journal=Laryngoscope |volume=107 |issue=8 |pages=1024–7 |date=August 1997 |pmid=9261001 |doi= |url=}}</ref>
* When the tumor is at an inaccessible location, clinical trial therapies (especially for stage IV disease) including:
** Therapeutic drugs
** Radiation
** Stem cell transplantation
** Monoclonal antibodies
* Either singly or in combination of various therapies
* Follow-up care with regular screening and check-ups are important<ref name="pmid26813873">{{cite journal |vauthors=Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K |title=Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity |journal=J Clin Diagn Res |volume=9 |issue=12 |pages=ZD03–4 |date=December 2015 |pmid=26813873 |pmc=4717804 |doi=10.7860/JCDR/2015/15595.6912 |url=}}</ref>
==Indications==
*Indications for surgery for mucoepidermoid carcinoma, include:<ref name="RapidisGivalos2007">{{cite journal|last1=Rapidis|first1=Alexander D.|last2=Givalos|first2=Nikolaos|last3=Gakiopoulou|first3=Hariklia|last4=Stavrianos|first4=Spyros D.|last5=Faratzis|first5=Gregory|last6=Lagogiannis|first6=George A.|last7=Katsilieris|first7=Ioannis|last8=Patsouris|first8=Efstratios|title=Mucoepidermoid carcinoma of the salivary glands.|journal=Oral Oncology|volume=43|issue=2|year=2007|pages=130–136|issn=13688375|doi=10.1016/j.oraloncology.2006.03.001}}</ref>
:*Biological and histological features suitable for surgery
==Gallery==
{{#ev:youtube|20sj0dJI6Xg}}


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
 
[[Category:Oral pathology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
 
[[Category:Medicine]]
[[Category:Oral pathology]]
[[Category:Otolaryngology]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 19:49, 22 January 2019

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma surgery

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma surgery

CDC on Mucoepidermoid carcinoma surgery

Mucoepidermoid carcinoma surgery in the news

Blogs on Mucoepidermoid carcinoma surgery

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

Surgery is the mainstay of therapy for mucoepidermoid carcinoma.

Surgery

  • Mucoepidermoid carcinoma (low-grade): complete surgical excision with sparing of the facial nerve.[1][1]
  • Mucoepidermoid carcinoma (high-grade): parotidectomy with facial nerve sparing may be followed by radiotherapy.
  • Clinically aggressive mucoepidermoid carcinoma tumors with facial nerve involvement will require radical surgery with sacrifice of the facial nerve and radiotherapy. [2]
  • Primary nerve grafting using the sural nerve if possible is performed.
  • Lymph node dissection is usually only performed for detected nodal metastasis.
  • Low grade mucoepidermoid carcinoma in the floor of the mouth can be surgically excised along with involved lymph node.[3][4]
  • When the tumor is at an inaccessible location, clinical trial therapies (especially for stage IV disease) including:
    • Therapeutic drugs
    • Radiation
    • Stem cell transplantation
    • Monoclonal antibodies
  • Either singly or in combination of various therapies
  • Follow-up care with regular screening and check-ups are important[5]

Indications

  • Indications for surgery for mucoepidermoid carcinoma, include:[6]
  • Biological and histological features suitable for surgery

Gallery

{{#ev:youtube|20sj0dJI6Xg}}

References

  1. 1.0 1.1 Mucoepidermoid Carcinoma Surgery. WikiBooks. https://en.wikibooks.org/wiki/Radiation_Oncology/Head_%26_Neck/Salivary_gland Accessed on February 17,2016
  2. Gedar Totuk OM, Demir MK, Yapicier O, Mestanoglu M (2017). "Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient". Case Rep Ophthalmol Med. 2017: 2418505. doi:10.1155/2017/2418505. PMC 5727657. PMID 29318070.
  3. Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A (January 2004). "Management of malignant sublingual salivary gland tumors". Oral Oncol. 40 (1): 2–5. PMID 14662408.
  4. Helmus C (August 1997). "Subtotal parotidectomy: a 10-year review (1985 to 1994)". Laryngoscope. 107 (8): 1024–7. PMID 9261001.
  5. Maloth AK, Nandan SR, Kulkarni PG, Dorankula SP, Muddana K (December 2015). "Mucoepidermoid Carcinoma of Floor of the Mouth - A Rarity". J Clin Diagn Res. 9 (12): ZD03–4. doi:10.7860/JCDR/2015/15595.6912. PMC 4717804. PMID 26813873.
  6. Rapidis, Alexander D.; Givalos, Nikolaos; Gakiopoulou, Hariklia; Stavrianos, Spyros D.; Faratzis, Gregory; Lagogiannis, George A.; Katsilieris, Ioannis; Patsouris, Efstratios (2007). "Mucoepidermoid carcinoma of the salivary glands". Oral Oncology. 43 (2): 130–136. doi:10.1016/j.oraloncology.2006.03.001. ISSN 1368-8375.

Template:WH Template:WS